European Patent Office

R 0011/20 (Petition for review - clearly unallowable) of 06.04.2022

European Case Law Identifier
ECLI:EP:BA:2022:R001120.20220406
Date of decision
6 April 2022
Case number
R 0011/20
Online on
6 July 2022
Petition for review of
-
Application number
05811874.6
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
METHODS FOR REFOLDING OF RECOMBINANT ANTIBODIES
Applicant name
Amgen Inc.
Opponent name
Hollatz, Christian
Cabinet Lavoix
Board
-
Headnote
-
Relevant legal provisions
European Patent Convention Art 112a(2)(c)European Patent Convention Art 112a(4)European Patent Convention Art 113(1)European Patent Convention R 107(1)Rules of procedure of the Boards of Appeal Art 12(2)Rules of procedure of the Boards of Appeal Art 12(4)Rules of procedure of the Boards of Appeal Art 13European Patent Convention R 109(2)(a)Rules of procedure of the Boards of Appeal Art 17(2)European Patent Convention Art 114(2)European Patent Convention Art 123(1)
Keywords
Petition for review - clearly unallowable
Petition for review - fundamental violation of Article 113 EPC (no)
Catchword
-

Order

For these reasons it is decided that:

The petition for review is unanimously rejected as being clearly unallowable.